Balyasny Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,212,745
Closed -$256M 2404
2023
Q3
$256M Buy
2,212,745
+848,150
+62% +$98.1M 0.52% 10
2023
Q2
$140M Buy
1,364,595
+502,189
+58% +$51.7M 0.31% 43
2023
Q1
$94.1M Sell
862,406
-741,412
-46% -$80.9M 0.24% 74
2022
Q4
$183M Buy
1,603,818
+440,287
+38% +$50.1M 0.5% 9
2022
Q3
$72M Buy
+1,163,531
New +$72M 0.22% 75
2021
Q3
Sell
-366,372
Closed -$34.3M 2319
2021
Q2
$34.3M Buy
366,372
+299,979
+452% +$28.1M 0.16% 135
2021
Q1
$6.11M Buy
+66,393
New +$6.11M 0.03% 526
2020
Q4
Sell
-178,635
Closed -$13.9M 1637
2020
Q3
$13.9M Buy
178,635
+123,042
+221% +$9.56M 0.1% 249
2020
Q2
$3.09M Sell
55,593
-411,656
-88% -$22.9M 0.03% 512
2020
Q1
$13.8M Sell
467,249
-488,028
-51% -$14.5M 0.16% 162
2019
Q4
$34.6M Buy
955,277
+675,840
+242% +$24.5M 0.21% 137
2019
Q3
$7.61M Sell
279,437
-570,560
-67% -$15.5M 0.05% 419
2019
Q2
$20.5M Buy
849,997
+324,497
+62% +$7.81M 0.13% 199
2019
Q1
$13.9M Sell
525,500
-340,523
-39% -$9M 0.09% 279
2018
Q4
$16.9M Buy
866,023
+536,770
+163% +$10.5M 0.12% 228
2018
Q3
$6.45M Buy
329,253
+260,313
+378% +$5.1M 0.03% 496
2018
Q2
$1.14M Sell
68,940
-121,278
-64% -$2.01M 0.01% 913
2018
Q1
$2.7M Sell
190,218
-935,295
-83% -$13.3M 0.01% 746
2017
Q4
$16.4M Buy
1,125,513
+1,033,313
+1,121% +$15.1M 0.05% 426
2017
Q3
$1.17M Sell
92,200
-1,083,739
-92% -$13.7M ﹤0.01% 931
2017
Q2
$14M Buy
+1,175,939
New +$14M 0.06% 367
2017
Q1
Sell
-29,984
Closed -$485K 1592
2016
Q4
$485K Buy
+29,984
New +$485K ﹤0.01% 956
2016
Q3
Sell
-534,640
Closed -$8.81M 1227
2016
Q2
$8.81M Buy
534,640
+524,610
+5,230% +$8.64M 0.06% 324
2016
Q1
$166K Buy
+10,030
New +$166K ﹤0.01% 948
2015
Q2
Hold
0
1178
2015
Q1
Hold
0
907
2014
Q4
Hold
0
692